These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24814269)

  • 1. Nitrogen bisphosphonate-induced orbital inflammatory disease: gamma delta T cells--a report and review of 2 cases.
    Vora MM; Rodgers IR; Uretsky S
    Ophthalmic Plast Reconstr Surg; 2014; 30(4):e84-5. PubMed ID: 24814269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-associated orbital inflammation--a case report and review.
    Peterson JD; Bedrossian EH
    Orbit; 2012 Apr; 31(2):119-23. PubMed ID: 22489855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital inflammatory disease after intravenous infusion of zoledronate for treatment of metastatic renal cell carcinoma.
    Phillips PM; Newman SA
    Arch Ophthalmol; 2008 Jan; 126(1):137-9. PubMed ID: 18195236
    [No Abstract]   [Full Text] [Related]  

  • 4. Orbital inflammation and optic neuropathy with zoledronic acid for metastatic prostate cancer.
    Seth A; Anderson DP; Albiani DA; Barton JJ
    Can J Ophthalmol; 2009 Aug; 44(4):467-8. PubMed ID: 19606178
    [No Abstract]   [Full Text] [Related]  

  • 5. A Case Series and Review of Bisphosphonate-associated Orbital Inflammation.
    Lefebvre DR; Mandeville JT; Yonekawa Y; Arroyo JG; Torun N; Freitag SK
    Ocul Immunol Inflamm; 2016; 24(2):134-9. PubMed ID: 25153041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.
    Herrera I; Kam Y; Whittaker TJ; Champion M; Ajlan RS
    BMC Ophthalmol; 2019 Feb; 19(1):51. PubMed ID: 30764790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute anterior uveitis following zoledronic acid infusion for osteoporosis.
    Belliveau MJ; Almeida DR; Urton TE
    Can J Ophthalmol; 2012 Oct; 47(5):e22-3. PubMed ID: 23036555
    [No Abstract]   [Full Text] [Related]  

  • 8. [Osteoporosis and bisphosphonates].
    Zuber MA
    Z Rheumatol; 2007 Dec; 66(8):713-5. PubMed ID: 17955251
    [No Abstract]   [Full Text] [Related]  

  • 9. Bisphosphonate-Induced Orbital Inflammation: A Case Series and Review.
    Pirbhai A; Rajak SN; Goold LA; Cunneen TS; Wilcsek G; Martin P; Leibovitch I; Selva D
    Orbit; 2015; 34(6):331-5. PubMed ID: 26540241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolendronate associated inflammatory orbital disease.
    Yeo J; Jafer AK
    N Z Med J; 2010 Sep; 123(1323):50-2. PubMed ID: 20930911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A once-yearly IV bisphosphonate for osteoporosis.
    Med Lett Drugs Ther; 2007 Nov; 49(1273):89-90. PubMed ID: 17975523
    [No Abstract]   [Full Text] [Related]  

  • 12. What do we know about the ocular adverse effects associated with intravenous bisphosphonates?
    Atik OS
    Eklem Hastalik Cerrahisi; 2011; 22(1):1. PubMed ID: 21417978
    [No Abstract]   [Full Text] [Related]  

  • 13. Orbital inflammatory disease in a patient treated with zoledronate.
    Kaur H; Uy C; Kelly J; Moses AM
    Endocr Pract; 2011; 17(4):e101-3. PubMed ID: 21803720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orbital inflammation after zoledronate infusion: an emerging complication.
    Rahimy E; Law SK
    Can J Ophthalmol; 2013 Feb; 48(1):e11-2. PubMed ID: 23419305
    [No Abstract]   [Full Text] [Related]  

  • 15. Fever with rash following zolendronic acid administration.
    Rizos EC; Milionis HJ; Elisaf MS
    Clin Exp Rheumatol; 2006; 24(4):455. PubMed ID: 16956442
    [No Abstract]   [Full Text] [Related]  

  • 16. Orbital Inflammation Secondary to Zoledronic Acid, a Rare Presentation.
    Muruganandam M; Sandhu H
    J Clin Rheumatol; 2016 Oct; 22(7):384. PubMed ID: 27488454
    [No Abstract]   [Full Text] [Related]  

  • 17. Avascular necrosis of the proximal carpal row of the wrist. A possible complication of bisphosphonate administration.
    Didden K; De Smet L; Vandenberghe L; Sciot R; Degreef I
    Chir Main; 2012 Dec; 31(6):355-7. PubMed ID: 23177907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB
    Ann Pharmacother; 2008 Jul; 42(7):1085-9. PubMed ID: 18505912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic acid: new indication. No therapeutic advantage in postmenopausal osteoporosis.
    Prescrire Int; 2008 Aug; 17(96):143. PubMed ID: 19480098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flare-up of hand osteoarthritis caused by zoledronic acid infusion.
    Werner de Castro GR; Neves FS; de Magalhães Souza Fialho SC; Pereira IA; Ribeiro G; Zimmermann AF
    Osteoporos Int; 2010 Sep; 21(9):1617-9. PubMed ID: 19936866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.